Annual EBITDA
Summary
- Current Value
- As of today, NBIX annual EBITDA is $666.60M, up +6.81% on
- Historical Performance
- NBIX annual EBITDA is up +150.32% over the past 3 years, up +98.33% over the past 5 years
- All-Time High Comparison
- NBIX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX annual EBITDA is +150.32% above its 3-year low of $266.30M reached on an earlier date
- Sector Comparison
- NBIX annual EBITDA is higher than 91.84% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $666.60M | +6.8% | +150.3% | +98.3% | +7126.5% | |
| Quarterly EBITDA | $193.30M | +517.6% | +457.1% | +468.5% | +8381.8% | |
| TTM EBITDA | $828.60M | +56.4% | +181.3% | +168.1% | +10000.0% | |
| Price | $152.25 | +29.6% | +55.5% | +67.2% | +1982.8% | |
| PE Ratio | 23.41 | -41.3% | -85.4% | +5.4% | -77.6% | |
| Annual Revenue | $2.86B | +21.4% | +92.2% | +173.5% | +8438.5% | |
| Annual EPS | $4.67 | +41.9% | +198.9% | +12.1% | +3212.9% | |
| $636.50M | +6.6% | +153.9% | +94.3% | +5927.1% | ||
| Annual Net Income | $478.60M | +40.2% | +209.8% | +17.5% | +6106.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $666.60M | at high | |
| 5Y | $666.60M | at high | |
| All | $666.60M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $266.30M | N/A | +150.3% |
| 5Y | $218.70M | +204.8% | |
| All | -$145.87M | +557.0% |
EBITDA History
FAQ
What is the current annual EBITDA of NBIX?
As of today, NBIX annual EBITDA is $666.60M
What is 1-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +6.81% year-over-year
What is 3-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +150.32% over the past 3 years
How far is NBIX annual EBITDA from its all-time high?
NBIX annual EBITDA is currently at its all-time high
How does NBIX annual EBITDA rank versus sector peers?
NBIX annual EBITDA is higher than 91.84% of companies in Healthcare sector
When is NBIX next annual earnings release?
As of today, the next annual earnings release for NBIX has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, NBIX quarterly EBITDA is $193.30M, down -17.88% on
- Historical Performance
- NBIX quarterly EBITDA is up +517.57% year-over-year, up +457.06% over the past 3 years
- All-Time High Comparison
- NBIX quarterly EBITDA is currently -21.74% below its historical high of $247.00M set on
- 3-Year Low Comparison
- NBIX quarterly EBITDA is +517.57% above its 3-year low of $31.30M reached on
- Sector Comparison
- NBIX quarterly EBITDA is higher than 92.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $193.30M | -17.9% | +517.6% | +457.1% | +468.5% | |
| Annual EBITDA | $666.60M | – | +6.8% | +150.3% | +98.3% | |
| TTM EBITDA | $828.60M | +24.3% | +56.4% | +181.3% | +168.1% | |
| Price | $152.25 | +7.8% | +29.6% | +55.5% | +67.2% | |
| PE Ratio | 23.41 | -22.6% | -41.3% | -85.4% | +5.4% | |
| Quarterly Revenue | $814.50M | +1.1% | +42.3% | +93.7% | +244.3% | |
| Quarterly EPS | $1.91 | +29.1% | +2382.4% | +342.6% | +485.5% | |
| $186.00M | -18.4% | +684.8% | +526.3% | +490.5% | ||
| Quarterly Net Income | $197.90M | +28.8% | +2405.1% | +358.4% | +516.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $247.00M | -21.7% | |
| 3Y | $247.00M | -21.7% | |
| 5Y | $247.00M | -21.7% | |
| All | $247.00M | -21.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $31.30M | N/A | +517.6% |
| 3Y | $31.30M | +517.6% | |
| 5Y | $6.40M | +2920.3% | |
| All | -$79.44M | +343.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NBIX?
As of today, NBIX quarterly EBITDA is $193.30M
What is NBIX quarterly EBITDA most recent change?
NBIX quarterly EBITDA was down -17.88% on March 31, 2026
What is 1-year change in NBIX quarterly EBITDA?
NBIX quarterly EBITDA is up +517.57% year-over-year
How far is NBIX quarterly EBITDA from its all-time high?
NBIX quarterly EBITDA is currently -21.74% below its historical high of $247.00M set on September 30, 2025
How does NBIX quarterly EBITDA rank versus sector peers?
NBIX quarterly EBITDA is higher than 92.09% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
TTM EBITDA
Summary
- Current Value
- As of today, NBIX TTM EBITDA is $828.60M, up +24.30% on
- Historical Performance
- NBIX TTM EBITDA is up +56.37% year-over-year, up +181.26% over the past 3 years
- All-Time High Comparison
- NBIX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX TTM EBITDA is +181.26% above its 3-year low of $294.60M reached on an earlier date
- Sector Comparison
- NBIX TTM EBITDA is higher than 92.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $828.60M | +24.3% | +56.4% | +181.3% | +168.1% | |
| Annual EBITDA | $666.60M | – | +6.8% | +150.3% | +98.3% | |
| Quarterly EBITDA | $193.30M | -17.9% | +517.6% | +457.1% | +468.5% | |
| Price | $152.25 | +7.8% | +29.6% | +55.5% | +67.2% | |
| PE Ratio | 23.41 | -22.6% | -41.3% | -85.4% | +5.4% | |
| TTM Revenue | $3.10B | +8.5% | +28.6% | +94.1% | +196.8% | |
| TTM EPS | $6.50 | +39.4% | +120.6% | +967.9% | +58.7% | |
| $798.80M | +25.5% | +59.3% | +188.1% | +166.2% | ||
| TTM Net Income | $668.60M | +39.7% | +118.6% | +944.7% | +66.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $828.60M | at high | |
| 3Y | $828.60M | at high | |
| 5Y | $828.60M | at high | |
| All | $828.60M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $527.60M | +57.0% | |
| 3Y | $294.60M | N/A | +181.3% |
| 5Y | $179.30M | +362.1% | |
| All | -$219.91M | +476.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NBIX?
As of today, NBIX TTM EBITDA is $828.60M
What is NBIX TTM EBITDA most recent change?
NBIX TTM EBITDA was up +24.30% on March 31, 2026
What is 1-year change in NBIX TTM EBITDA?
NBIX TTM EBITDA is up +56.37% year-over-year
How far is NBIX TTM EBITDA from its all-time high?
NBIX TTM EBITDA is currently at its all-time high
How does NBIX TTM EBITDA rank versus sector peers?
NBIX TTM EBITDA is higher than 92.18% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
EBITDA Formula
Data Sources & References
- NBIX Official Website www.neurocrine.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
- NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
- NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix
